Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 2507-2522

  Saxena, Sandeep ^a   Srivastav, Khushboo ^a   Cheung, Chui M ^b   Ng, Joanne Y W ^c   Lai, Timothy Y Y ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Age relate macular degeneration; Diabetic macular edema; External limiting membrane; Inner segment outer segment junction; Macular hole; Spectral domain optical coherence tomography

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

BEHCET DISEASE; CENTRAL RETINA VEIN OCCLUSION; CENTRAL SEROUS RETINOPATHY; CHOROIDAL HEMANGIOMA; DIABETIC MACULAR EDEMA; EPIRETINAL MEMBRANE; FLUORESCENCE ANGIOGRAPHY; HEMANGIOMA; HUMAN; MACULAR DEGENERATION; MACULAR TELANGIECTASIA; OBSERVATIONAL STUDY; OCCULT OUTER RETINOPATHY; PHOTODYNAMIC THERAPY; PHOTORECEPTOR INNER SEGMENT; PIGMENT EPITHELIUM; PROGNOSIS; RETINA DETACHMENT; RETINA FOVEA; RETINA MACULA LUTEA; RETINITIS PIGMENTOSA; RETINOPATHY; RETINOSCHISIS; RETROSPECTIVE STUDY; REVIEW; SCLERA BUCKLING PROCEDURE; SOLAR RETINOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STARGARDT DISEASE; SUBRETINAL NEOVASCULARIZATION; SYMPATHETIC OPHTHALMIA; TELANGIECTASIA; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINOPATHY; VOGT KOYANAGI SYNDROME;

EID: 84916892206     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S72132     Document Type: Review

References (149)

1. Chang LK, Koizumi H, Spaide RF. Disruption of the photoreceptor inner segment-outer segment junction in eyes with macular holes. Retina. 2008;28(7):969–975.
2. Spaide RF, Koizumi H, Freund KB. Photoreceptor outer segment abnormalities as a cause of blind spot enlargement in acute zonal occult outer retinopathy-complex diseases. Am J Ophthalmol. 2008;146(1): 111–120.
3. Wang NK, Chou CL, Lima LH, et al. Fundus autofuorescence in cone dystrophy. Doc Ophthalmol. 2009;119(2):141–144.
4. Oh J, Smiddy WE, Flynn HW Jr, Gregori G, Lujan B. Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol Vis Sci. 2010;51(3):1651–1658.
5. Inoue M, Morita S, Watanabe Y, et al. Inner segment/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane. Am J Ophthalmol. 2010; 150(6):834–839.
6. Hood DC, Lazow MA, Locke KG, Greenstein VC, Birch DG. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52(1):101–108.
7. Kitaguchi Y, Kusaka S, Yamaguchi T, Mihashi T, Fujikado T. Detection of photoreceptor disruption by adaptive optics fundus imaging and Fourier-domain optical coherence tomography in eyes with occult macular dystrophy. Clin Ophthalmol. 2011;5:345–351.
8. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121(5):695–706.
9. Ko TH, Fujimoto JG, Duker JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. Ophthalmology. 2004;111(11):2033–2043.
10. Srinivasan VJ, Ko TH, Wojtkowski M, et al. Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2006;47(12):5522–5528.
11. Srinivasan VJ, Monson BK, Wojtkowski M, et al. Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2008; 49(4):1571–1579.
12. Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y. The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol. 2010;150(1): 27–32.e1.
13. Zawadzki RJ, Jones SM, Olivier SS, et al. Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in vivo imaging. Opt Express. 2005;13(21):8532–8546.
14. Puche N, Querques G, Benhamou N, et al. High-resolution spectral domain optical coherence tomography features in adult onset foveomac-ular vitelliform dystrophy. Br J Ophthalmol. 2010;94(9):1190–1196.
15. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31(8):1609–1619.
16. Anger EM, Unterhuber A, Hermann B, et al. Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections. Exp Eye Res. 2004; 78(6):1117–1125.
17. Spaide RF. Questioning optical coherence tomography. Ophthalmology. 2012;119(11):2203–2204.e1.
18. Krebs W, Krebs I. Primate Retina and Choroid: Atlas of Fine Structure in Man and Monkey. New York, NY: Springer-Verlag; 1991.
19. Hogan JA, Alvarado MJ, Weddell JE. Histology of the Human Eye: An Atlas and Textbook. Philadelphia, PA: WB Saunders; 1971.
20. Fernandez EJ, Hermann B, Povazay B, et al. Ultrahigh resolution optical coherence tomography and pancorrection for cellular imaging of the living human retina. Opt Express. 2008;16(15):11083–11094.
21. Lu RW, Curcio CA, Zhang Y, et al. Investigation of the hyper-reflective inner/outer segment band in optical coherence tomography of living frog retina. J Biomed Opt. 2012; 17(6):060504.
22. Fernandez EJ, Povazay B, Hermann B, et al. Three-dimensional adaptive optics ultrahigh-resolution optical coherence tomography using a liquid crystal spatial light modulator. Vision Res. 2005;45(28):3432–3444.
23. Zhang Y, Cense B, Rha J, et al. High-speed volumetric imaging of cone photoreceptors with adaptive optics spectral-domain optical coherence tomography. Opt Express. 2006;14(10):4380–4394.
24. Sano M, Shimoda Y, Hashimoto H, Kishi S. Restored photoreceptor outer segment and visual recovery after macular hole closure. Am J Ophthalmol. 2009;147(2):313–318.e1.
25. Baba T, Yamamoto S, Arai M, et al. Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina. 2008;28(3): 453–458.
26. Wakabayashi T, Fujiwara M, Sakaguchi H, Kusaka S, Oshima Y. Foveal microstructure and visual acuity in surgically closed macu-lar holes: spectral-domain optical coherence tomographic analysis. Ophthalmology. 2010;117(9):1815–1824.
27. Bottoni F, De Angelis S, Luccarelli S, Cigada M, Staurenghi G. The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2011;52(7):4439–4446.
28. Theodossiadis PG, Grigoropoulos VG, Theodossiadis GP. The significance of the external limiting membrane in the recovery of photoreceptor layer after successful macular hole closure: a study by spectral domain optical coherence tomography. Ophthalmologica. 2011; 225(3):176–184.
29. Shimozono M, Oishi A, Hata M, Kurimoto Y. Restoration of the photo-receptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis. Graefes Arch Clin Exp Ophthalmol. 2011;249(10):1469–1476.
30. Ruiz-Moreno JM, Lugo F, Montero JA, Pinero DP. Restoration of macular structure as the determining factor for macular hole surgery outcome. Graefes Arch Clin Exp Ophthalmol. 2012;250(10):1409–1414.
31. Itoh Y, Inoue M, Rii T, Hiraoka T, Hirakata A. Significant correlation between visual acuity and recovery of foveal cone microstructures after macular hole surgery. Am J Ophthalmol. 2012;153(1):111–119.e1.
32. Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol. 2000;129(6): 769–777.
33. Mitamura Y, Hirano K, Baba T, Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br J Ophthalmol. 2009;93(2):171–175.
34. Suh MH, Seo JM, Park KH, Yu HG. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am J Ophthalmol. 2009;147(3): 473–480.e3.
35. Oster SF, Mojana F, Brar M, Yuson RM, Cheng L, Freeman WR. Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010;30(5): 713–718.
36. Falkner-Radler CI, Glittenberg C, Hagen S, Benesch T, Binder S. Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology. 2010;117(4):798–805.
37. Theodossiadis PG, Theodossiadis GP, Charonis A, Emfetzoglou I, Grigoropoulos VG, Liarakos VS. The photoreceptor layer as a prognostic factor for visual acuity in the secondary epiretinal membrane after retinal detachment surgery: imaging analysis by spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;151(6):973–980.
38. Brito PN, Gomes NL, Vieira MP, et al. Possible role for fundus autofluorescence as a predictive factor for visual acuity recovery after epiretinal membrane surgery. Retina. 2014;34(2):273–280.
39. Okamoto F, Sugiura Y, Okamoto Y, Hiraoka T, Oshika T. Associations between metamorphopsia and foveal microstructure in patients with epiretinal membrane. Invest Ophthalmol Vis Sci. 2012;53(11):6770–6775.
40. Shimozono M, Oishi A, Hata M, et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. 2012;153(4):698–704, 704.e1.
41. Watanabe K, Tsunoda K, Mizuno Y, Akiyama K, Noda T. Outer retinal morphology and visual function in patients with idiopathic epiretinal membrane. JAMA Ophthalmol. 2013;131(2):172–177.
42. Cobos E, Arias L, Ruiz-Moreno J, et al. Preoperative study of the inner segment/outer segment junction of photoreceptors by spectral-domain optical coherence tomography as a prognostic factor in patients with epiretinal membranes. Clin Ophthalmol. 2013;7:1467–1470.
43. Shiono A, Kogo J, Klose G, et al. Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membrane surgery. Ophthalmology. 2013;120(4):788–794.
44. Bae SH, Kim D, Park TK, Han JR, Kim H, Nam W. Preferential hyperacuity perimeter and prognostic factors for metamorphopsia after idiopathic epiretinal membrane surgery. Am J Ophthalmol. 2013; 155(1):109–117.e3.
45. Schocket LS, Witkin AJ, Fujimoto JG, et al. Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology. 2006;113(4):666–672.
46. Wakabayashi T, Oshima Y, Fujimoto H, et al. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology. 2009; 116(3):519–528.
47. Cho M, Witmer MT, Favarone G, Chan RP, D’Amico DJ, Kiss S. Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment. Clin Ophthalmol. 2012;6:91–96.
48. Delolme MP, Dugas B, Nicot F, Muselier A, Bron AM, Creuzot-Garcher C. Anatomical and functional macular changes after rhegmatog-enous retinal detachment with macula off. Am J Ophthalmol. 2012; 153(1):128–136.
49. Joe SG, Kim YJ, Chae JB, et al. Structural recovery of the detached macula after retinal detachment repair as assessed by optical coherence tomography. Korean J Ophthalmol. 2013;27(3):178–185.
50. Akkoyun I, Yilmaz G. [Optical coherence tomography: anatomic and functional outcome after scleral buckling surgery in macula-off rhegmatogenous retinal detachment]. Klin Monbl Augenheilkd. 2013;230(8):814–819. German.
51. Fujimoto S, Ikuno Y, Nishida K. Postoperative optical coherence tomographic appearance and relation to visual acuity after vitrectomy for myopic foveoschisis. Am J Ophthalmol. 2013;156(5):968–973.e1.
52. Saxena S, Manisha, Meyer CH. Three-dimensional spectral domain optical coherence tomography in X linked foveal retinoschisis. BMJ Case Rep. 2013;2013.
53. Sayanagi K, Ikuno Y, Soga K, Tano Y. Photoreceptor inner and outer segment defects in myopic foveoschisis. Am J Ophthalmol. 2008; 145(5):902–908.
54. Gerendas BS, Kroisamer JS, Sulzbacher F, Schmidt-Erfurth U. Neovascular age-related macular degeneration. In: Midena E, editor. Microperimetry and Multimodal Retinal Imaging. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg; 2014.
55. Pilotto E, Benetti E, Convento E, et al. Microperimetry, fundus autofuorescence, and retinal layer changes in progressing geographic atrophy. Can J Ophthalmol. 2013;48(5):386–393.
56. Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol. 2009;148(1):83–89.e1.
57. Chhablani J, Kim JS, Freeman WR, Kozak I, Wang HY, Cheng L. Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy. Int J Ophthalmol. 2013;6(1):62–66.
58. Oishi A, Shimozono M, Mandai M, Hata M, Nishida A, Kurimoto Y. Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2013;251(2):435–440.
59. Hartmann KI, Gomez ML, Bartsch DU, Schuster AK, Freeman WR. Effect of change in drusen evolution on photoreceptor inner segment/ outer segment junction. Retina. 2012;32(8):1492–1499.
60. Mrejen S, Sato T, Curcio CA, Spaide RF. Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft Drusen in vivo using adaptive optics imaging. Ophthalmology. 2014;121(2):545–551.
61. Curcio CA, Messinger JD, Sloan KR, McGwin G, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina. 2013;33(2):265–276.
62. Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol. 2007; 91(2):157–160.
63. Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol. 2007;91(2):161–165.
64. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology. 2007;114(12):2190–2196.
65. Hernandez-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, et al. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina. 2007; 27(6):707–712.
66. Chan WM, Lai TY, Chan KP, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina. 2008;28(9):1308–1313.
67. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study. Br J Ophthalmol. 2009;93(2):150–154.
68. Ikuno Y, Nagai Y, Matsuda S, et al. Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol. 2010;149(1): 140–146.
69. Ruiz-Moreno JM, Montero JA, Arias L, et al. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization. Retina. 2010;30(10):1609–1615.
70. Scupola A, Tiberti AC, Sasso P, et al. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results. Retina. 2010;30(5):739–747.
71. Wakabayashi T, Ikuno Y, Gomi F. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia. Retina. 2011;31(5):880–886.
72. Gharbiya M, Giustolisi R, Allievi F, et al. Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab – a randomized controlled trial. Am J Ophthalmol. 2010;149(3): 458–464.e1.
73. Silva RM, Ruiz-Moreno JM, Nascimento J, et al. Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina. 2008;28(8):1117–1123.
74. Lai TY, Chan WM, Liu DT, Lam DS. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Retina. 2009;29(6):750–756.
75. Mones JM, Amselem L, Serrano A, Garcia M, Hijano M. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye (Lond). 2009;23(6):1275–1280; quiz 1281.
76. Lalloum F, Souied EH, Bastuji-Garin S, et al. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina. 2010;30(3):399–406.
77. Silva RM, Ruiz-Moreno JM, Rosa P, et al. Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results. Retina. 2010;30(3):407–412.
78. Varano M, Tedeschi M, Oddone F, Perillo L, Coppe AM, Parravano M. Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab. Retina. 2010;30(3):413–417.
79. Heier JS, Brown D, Ciulla T, et al. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011;118(1):111–118.
80. Gharbiya M, Allievi F, Confitti S, et al. Intravitreal bevacizumab for treatment of myopic choroidal neovascularization: the second year of a prospective study. Clin Ter. 2010;161(3):e87–e93.
81. Ruiz-Moreno JM, Montero JA. Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome. Graefes Arch Clin Exp Ophthalmol. 2010;248(7):937–941.
82. Asai T, Ikuno Y, Nishida K. Macular microstructures and prognostic factors in myopic subretinal hemorrhages. Invest Ophthalmol Vis Sci. 2014;55(1):226–232.
83. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol. 2006;142(3):405–412.
84. Maheshwary AS, Oster SF, Yuson RM, Cheng L, Mojana F, Freeman WR. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol. 2010;150(1):63–67.e1.
85. Saxena S, Jain A. Alterations in “in vivo” histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab. J Ocul Biol Dis Infor. 2011;4(4):137–140.
86. Jain A, Saxena S, Khanna VK, Shukla RK, Meyer CH. Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis. 2013;19:1760–1768.
87. Uji A, Murakami T, Nishijima K, et al. Association between hyperrefective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol. 2012;153(4):710–717, 717.e1.
88. Yanyali A, Bozkurt KT, Macin A, Horozoglu F, Nohutcu AF. Quantitative assessment of photoreceptor layer in eyes with resolved edema after pars plana vitrectomy with internal limiting membrane removal for diabetic macular edema. Ophthalmologica. 2011;226(2): 57–63.
89. Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):61–70.
90. Chung H, Park B, Shin HJ, Kim HC. Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema. Ophthalmology. 2012;119(5):1056–1065.
91. Wakabayashi Y, Kimura K, Muramatsu D, et al. Axial length as a factor associated with visual outcome after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci. 2013;54(10):6834–6840.
92. Ota M, Tsujikawa A, Kita M, et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina. 2008;28(10):1502–1508.
93. Lima VC, Yeung L, Castro LC, Landa G, Rosen RB. Correlation between spectral domain optical coherence tomography findings and visual outcomes in central retinal vein occlusion. Clin Ophthalmol. 2011;5:299–305.
94. Shin HJ, Chung H, Kim HC. Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion. Acta Ophthalmol. 2011;89(1):e35–e40.
95. Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113(1):48–57.
96. Sallo FB, Peto T, Egan C, et al. “En face” OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci.2012;53(10):6145–6152.
97. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006; 124(4):450–460.
98. Charbel Issa P, Gillies MC, Chew EY, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;34:49–77.
99. Matsumoto H, Kishi S, Otani T, Sato T. Elongation of photoreceptor outer segment in central serous chorioretinopathy. Am J Ophthalmol. 2008;145(1):162–168.
100. Kon Y, Iida T, Maruko I, Saito M. The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates. Retina. 2008;28(6):864–869.
101. Piccolino FC, De La Longrais RR, Manea M, Cicinelli S. Posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina. 2008;28(7):1008–1012.
102. Ojima Y, Hangai M, Sasahara M, et al. Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology. 2007;114(12):2197–2207.
103. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol. 2005;139(1):87–99.
104. Ojima A, Iida T, Sekiryu T, Maruko I, Sugano Y. Photopigments in central serous chorioretinopathy. Am J Ophthalmol.2011;151(6):940–952.e1.
105. Fujita K, Shinoda K, Imamura Y, et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol. 2012;154(3):579–585.
106. Vasconcelos H, Marques I, Santos AR, et al. Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2013;251(7):1697–1705.
107. Ozdemir O, Erol MK. Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab. Cutan Ocul Toxicol. 2014;33(2):122–126.
108. Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol. 2009;148(1):105–110.e1.
109. Kim SW, Oh J, Huh K. Correlations among various functional and morphological tests in resolved central serous chorioretinopathy. Br J Ophthalmol. 2012;96(3):350–355.
110. Ojima Y, Tsujikawa A, Hangai M, et al. Retinal sensitivity measured with the micro perimeter 1 after resolution of central serous chorioretinopathy. Am J Ophthalmol. 2008;146(1):77–84.
111. Ozdemir H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O. Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye (Lond). 2008;22(2):204–208.
112. Aizawa S, Mitamura Y, Baba T, Hagiwara A, Ogata K, Yamamoto S. Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa. Eye (Lond). 2009;23(2):304–308.
113. Oishi A, Otani A, Sasahara M, et al. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa. Eye (Lond). 2009;23(6):1411–1416.
114. Sugita T, Kondo M, Piao CH, Ito Y, Terasaki H. Correlation between macular volume and focal macular electroretinogram in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008; 49(8):3551–3558.
115. Wakabayashi T, Sawa M, Gomi F, Tsujikawa M. Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol. 2010;88(5):e177–e183.
116. Iriyama A, Yanagi Y. Fundus autofluorescence and retinal structure as determined by spectral domain optical coherence tomography, and retinal function in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):333–339.
117. Aizawa S, Mitamura Y, Hagiwara A, Sugawara T, Yamamoto S. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Experiment Ophthalmol. 2010;38(6):597–604.
118. Tamaki M, Matsuo T. Optical coherence tomographic parameters as objective signs for visual acuity in patients with retinitis pigmentosa, future candidates for retinal prostheses. J Artif Organs. 2011;14(2): 140–150.
119. Lima LH, Sallum JM, Spaide RF. Outer retina analysis by optical coherence tomography in cone-rod dystrophy patients. Retina. 2013;33(9): 1877–1880.
120. Inui E, Oishi A, Oishi M, et al. Tomographic comparison of cone-rod and rod-cone retinal dystrophies. Graefes Arch Clin Exp Ophthalmol. 2014;1–5.
121. Yang P, Michaels KV, Courtney RJ, et al. Retinal Morphology of Patients With Achromatopsia During Early Childhood: Implications for Gene Therapy. JAMA Ophthalmol. 2014.
122. Greenberg JP, Sherman J, Zweifel SA, et al. Spectral-domain optical coherence tomography staging and autofluorescence imaging in achromatopsia. JAMA Ophthalmol. 2014;132(4):437–445.
123. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–3959.
124. Testa F, Rossi S, Sodi A, et al. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy. Invest Ophthalmol Vis Sci. 2012; 53(8):4409–4415.
125. Rencova E, Studnicka J, Marak J, Dvorakova H, Langrova H. [The coincidence of the junction layer of inner and outer photoreceptors segments (IS/OS) defects localization on SD OCT and functional defects in case of Stargardt disease – a case report]. Cesk Slov Oftalmol. 2012;68(2):84–86, 88. Czech.
126. Koizumi H, Maguire JI, Spaide RF. Spectral domain optical coherence tomographic fndings of occult macular dystrophy. Ophthalmic Surg Lasers Imaging. 2009;40(2):174–176.
127. Kim YG, Baek SH, Moon SW, Lee HK, Kim US. Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol. 2011;89(1):e52–e56.
128. Hangai M, Fujimoto M, Yoshimura N. Features and function of multiple evanescent white dot syndrome. Arch Ophthalmol. 2009; 127(10):1307–1313.
129. Nguyen MH, Witkin AJ, Reichel E, et al. Microstructural abnormalities in MEWDS demonstrated by ultrahigh resolution optical coherence tomography. Retina. 2007;27(4):414–418.
130. Tsunoda K, Fujinami K, Miyake Y. Selective abnormality of cone outer segment tip line in acute zonal occult outer retinopathy as observed by spectral-domain optical coherence tomography. Arch Ophthalmol. 2011;129(8):1099–1101.
131. Wolff E. The external limiting membrane of the retina and its relation to Verhoeff’s membrane. Trans Ophthalmol Soc U K. 1950;60:61–67.
132. Joussen F, Spitznas M. The fine structure of the human retina at the ora serrata. Albrecht Vo n Graefes Arch Klin Exp Ophthalmol. 1972;185(3): 177–188.
133. Feeney L. Editorial: Intercellular junctions: sites of permeability barriers and cellular communication. Invest Ophthalmol. 1974;13(11): 811–814.
134. Chen KC, Jung JJ, Alzman A. High definition spectral domain optical coherence tomography findings in three patients with solar retinopathy and review of the literature. Open Ophthalmol J. 2012;6:29–35.
135. Klemencic S, McMahon J, Upadhyay S, Messner L. Spectral domain optical coherence tomography as a predictor of visual function in chronic solar maculopathy. Optom Vis Sci. 2011;88(8):1014–1019.
136. Jain A, Desai RU, Charalel RA, Quiram P, Yannuzzi L, Sarraf D. Solar retinopathy: comparison of optical coherence tomography (OCT) and fluorescein angiography (FA). Retina. 2009;29(9):1340–1345.
137. Chen RW, Gorczynska I, Srinivasan VJ, Fujimoto JG, Duker JS, Reichel E. High-speed ultrahigh-resolution optical coherence tomography findings in chronic solar retinopathy. Retin Cases Brief Rep. 2008;2(2):103–105.
138. Jorge R, Costa RA, Quirino LS, et al. Optical coherence tomography findings in patients with late solar retinopathy. Am J Ophthalmol. 2004;137(6):1139–1143.
139. Iannetti L, Spinucci G, Abbouda A, De Geronimo D, Tortorella P, Accorinti M. Spectral-domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors. Ophthalmologica. 2012;228(1):13–18.
140. Iannetti L, Tortorella P, D’Ambrosio E, Spena R, Zito R, Gharbiya M. Epiretinal membranes in patients with uveitis: morphological and functional analysis with spectral domain optical coherence tomography. Biomed Res Int. 2013;2013:284821.
141. Gupta V, Gupta A, Dogra MR, Singh I. Reversible retinal changes in the acute stage of sympathetic ophthalmia seen on spectral domain optical coherence tomography. Int Ophthalmol. 2011;31(2): 105–110.
142. Ishihara K, Hangai M, Kita M, Yoshimura N. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology. 2009;116(9):1799–1807.
143. Unoki N, Nishijima K, Kita M, Hayashi R, Yoshimura N. Structural changes of fovea during remission of Behcet’s disease as imaged by spectral domain optical coherence tomography. Eye (Lond). 2010; 24(6):969–975.
144. Liu W, Zhang Y, Xu G, Qian J, Jiang C, Li L. Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma. Retina. 2011;31(2): 336–343.
145. Stepien KE, Han DP, Schell J, Godara P, Rha J, Carroll J. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc. 2009;107:28–33.
146. Rodriguez-Padilla JA, Hedges TR, 3rd, Monson B, et al. Highspeed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol. 2007; 125(6):775–780.
147. Kellner S, Weinitz S, Kellner U. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol. 2009;93(11): 1444–1447.
148. Kelmenson AT, Brar VS, Murthy RK, Chalam KV. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy. Eur J Ophthalmol. 2010;20(4):785–788.
149. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118(2):415–422.